Horseradish peroxidase-mediated gene therapy: Choice of prodrugs in oxic and anoxic tumor conditions

Molecular Cancer Therapeutics

Volumn 1, Issue 2, 2001, Pages 151-160

  Greco, Olga ^a   Rossiter, Sharon ^a   Kanthou, Chryso ^a   Folkes, Lisa K ^a   Wardman, Peter ^a   Tozer, Gillian M ^a   Dachs, Gabi U ^a  

^a Gray Cancer Institute   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HORSERADISH PEROXIDASE; INDOLEACETIC ACID DERIVATIVE; OXYGEN; PRODRUG;

ARTICLE; CELL CULTURE; CELL DIVISION; CELL HYPOXIA; DRUG EFFECT; DRUG SCREENING; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PLASMID; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL DIVISION; CELL HYPOXIA; COMBINED MODALITY THERAPY; GENE THERAPY; HORSERADISH PEROXIDASE; HUMANS; INDOLEACETIC ACIDS; OXYGEN; PLASMIDS; PRODRUGS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0035554093     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Human gene marker/therapy clinical protocols. Hum. Gene Ther., 11: 2543-2619, 2000.
2. Greco, O., and Dachs, G. U. Gene-directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives. J. Cell. Physiol., 187: 22-36, 2001. (Pubitemid 32195242)
3. Moolten, F. L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res., 46: 5276-5281, 1986. (Pubitemid 16008301)
4. Greco, O., Folkes, L. K., Wardman, P., Tozer, G. M., and Dachs, G. U. Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. Cancer Gene Ther., 7: 1414-1420, 2000.
5. Dachs, G. U., and Tozer, G. M. Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur. J. Cancer, 36: 1649-1660, 2000. (Pubitemid 30616369)
6. Folkes, L. K., and Wardman, P. Oxidative activation of indole-3-acetic acids to cytotoxic species: a potential new role for plant auxins in cancer therapy. Biochem. Pharmacol., 61: 129-136, 2001. (Pubitemid 32121777)
7. Melton, R. G., and Sherwood, R. F. Antibody-enzyme conjugates for cancer therapy. J. Natl. Cancer Inst. (Bethesda), 88: 153-165, 1996. (Pubitemid 26065827)
8. Connors, T. A., Duncan, R., and Knox, R. J. The chemotherapy of colon cancer. Eur. J. Cancer, 31A: 1373-1378, 1995.
9. Mirsky, I. A., and Diengott, D. Hypoglycemic action of indole-3-acetic acid by mouth in patients with diabetes mellitus. Proc. Soc. Exp. Biol. Med., 93: 109-110, 1956.
10. Folkes, L. K., Candeias, L. P., and Wardman, P. Towards targeted "oxidation therapy" of cancer: peroxidase-catalyzed cytotoxicity of indole-3-acetic acids. Int. J. Radiat. Oncol. Biol. Phys., 42: 917-920, 1998. (Pubitemid 28559443)
11. Pires de Melo, M., Pithon Curi, T. C., Curi, R., Di Mascio, P., and Cilento, G. Peroxidase activity may play a role in the cytotoxic effect of indole acetic acid. Photochem. Photobiol., 65: 338-341, 1997.
12. Pires de Melo, M., Curi, T. C., Miyasaka, C. K., Palanch, A. C., and Curi, R. Effect of indole acetic acid on oxygen metabolism in cultured rat neutrophil. Gen. Pharmacol., 31: 573-578, 1998. (Pubitemid 28458926)
13. Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C., and Lawley, T. J. HMEC-1: establishment of an immortalised human microvascular endothelial cell line. J. Investig. Dermatol., 99: 683-690, 1992. (Pubitemid 23002027)
14. Connolly, C. N., Futter, C. E., Gibson, A., Hopkins, C. R., and Cutler, D. F. Transport into and out the Golgi complex studied by transfecting cells with cDNAs encoding horseradish peroxidase. J. Cell Biol., 127: 641-652, 1994. (Pubitemid 24332962)
15. Dachs, G. U., Coralli, C., Hart, S. L., and Tozer, G. M. Gene delivery to hypoxic cells in vitro. Br. J. Cancer, 83: 662-667, 2000. (Pubitemid 30636310)
16. Hart, S. L., Arancibia-Cárcamo, C. V., Wolfert, M. A., O'Reilly, N. J., Ali, R. R., Coutelle, C., George, A. J., Harbottle, R. P., Knight, A. M., Larkin, D. F., Levinsky, R. J., Seymour, L. W., Thrasher, A. J., and Kinnon, C. Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Hum. Gene Ther., 9: 575-585, 1998.
17. Dillard, R. D., Bach, N. J., Draheim, S. E., Berry, D. R., Carlson, D. G., Chirgadze, N. Y., Clawson, D. K., Hartley, L. W., Johnson, L. M., Jones, N. D., McKinney, E. R., Mihelich, E. D., Olkowski, J. L., Schevitz, R. W., Smith, A. C., Snyder, D. W., Sommers, C. D., and Wery, J. P. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides. J. Med. Chem., 39: 5119-5136, 1996. (Pubitemid 27008959)
18. Batcho, A. D., and Leimgruber, W. Indoles from 2-methylnitrobenzenes by condensation with formamide acetals followed by reduction: 4-benzyloxyindole. Organic Syntheses, 63: 214-225, 1985.
19. Carrera, G. M., and Sheppard, G. S. Synthesis of 6- and 7-arylindoles via palladium-catalyzed cross-coupling of 6- and 7-bromoindole with arylboronic acids. Synlett, 93-94, 1994.
20. Wosikowski, K., Regis, J. T., Robey, R. W., Alvarez, M., Buters, J. T., Gudas, J. M., and Bates, S. E. Normal p53 status and function despite the development of drug resistance in human breast cancer cells. Cell Growth Differ., 6: 1395-1403, 1995.
21. Reiss, M., Brash, D. E., Munoz-Antonia, T., Simon, J. A., Ziegler, A., Vellucci, V. F., and Zhou, Z. L. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines. Oncol. Res., 4: 349-357, 1992. (Pubitemid 23167119)
22. Kawasaki, T., Tomita, Y., Bilim, V., Takeda, M., Takahashi, K., and Kumanishi, T. Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations. Int. J. Cancer, 68: 501-505, 1996. (Pubitemid 26414506)
23. Elshami, A. A., Saavedra, A., Zhang, H., Kucharczuk, J. C., Spray, D. C., Fishman, G. I., Amin, K. M., Kaiser, L. R., and Albeda, S. M. Gap junctions play a role in the "bystander effect" of the herpes simplex virus thymidine kinase ganciclovir system in vitro. Gene Ther., 3: 85-92, 1996. (Pubitemid 26088496)
24. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993. (Pubitemid 23333399)
25. Huber, B. E., Austin, E. A., Richards, C. A., Davis, S. T., and Good, S. S. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA, 91: 8302-8306, 1994.
26. Bridgewater, J. A., Knox, R. J., Pitts, J. D., Collins, M. K., and Springer, C. J. The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite. Hum. Gene Ther., 8: 709-717, 1997. (Pubitemid 27202057)
27. Lawrence, T. S., Rehemtulla, A., Ng, E. Y., Wilson, M., Trosko, J. E., and Stetson, P. L. Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine. Cancer Res., 58: 2588-2593, 1998. (Pubitemid 28275430)
28. Spooner, R. A., Maycroft, K. A., Paterson, H., Friedlos, F., Springer, C. J., and Marais, R. Appropriate subcellular localisation of prodrug-activating enzymes important consequences for suicide gene therapy. Int. J. Cancer, 93: 123-130, 2001. (Pubitemid 32539511)
29. Dachs, G. U., Patterson, A. V., Firth, J. D., Ratcliffe, P. J., Townsend, K. M., Stratford, I. J., and Harris, A. L. Targeting gene expression to hypoxic tumor cells. Nat. Med., 3: 515-520, 1997. (Pubitemid 27198648)